We are thrilled to announce our collaboration with Elanco, a global leader focused on developing and marketing innovative solutions that enhance companion animal health. Our collaboration brings together FitBark and Galliprant (grapiprant tablets) within select veterinary clinics across the U.S.

FitBark_Elanco_Logo-900x451-350x175 | FitBark and Elanco team up to promote pet health and well-being

Since 1954, Elanco has been working to empower veterinarians, food producers, and all those concerned with animal health with the tools needed to help animals live healthy lives. Elanco makes an ideal partner for FitBark to foster healthier pets, healthier humans and a healthier environment.

In the words of Kayci Spandau, Marketing Associate at Elanco:

FitBark_Elanco_Kayci_Spandau-350x263 | FitBark and Elanco team up to promote pet health and well-being

“Pet owners know their dog better than anyone, but it is often difficult to notice subtle changes in pet’s behavior and movement that could be a sign of a physical condition like osteoarthritis, which afflicts one in five dogs1. Elanco’s commitment to helping pets, their owners and veterinarians fits in perfectly with FitBark’s mission of allowing pet owners to not only be active with their dog, but to also monitor behavior throughout the day. With the help of your veterinarian, you may be able to notice critical patterns that you may otherwise miss. To learn more about canine osteoarthritis and Galliprant, please visit Galliprantfordogs.com

We are proud to share our One Health vision with Elanco. Look for FitBark at thousands of veterinary clinics nationwide!


About Elanco

Elanco Animal Health provides innovation and veterinary support to help pets live longer, healthier, higher-quality lives. Please visit www.elanco.us to learn more.

INDICATION
Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.

IMPORTANT SAFETY INFORMATION
Not for use in humans. Keep out of reach of children and pets. Monitoring is recommended if used long term. Should not be used in dogs who are allergic to grapiprant or with other anti-inflammatory drugs. The safe use of Galliprant has not been studied in dogs younger than 9 months of age and less than 8 pounds, breeding, pregnant or lactating dogs, or dogs with heart disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite and tiredness. View full product label for complete safety information or contact your veterinarian.

REFERENCES
1Johnston, SA. Osteoarthritis: joint anatomy, physiology, and pathobiology. Veterinary Clinics of North America: Small Animal Practice. 1997; 27:699-723.

© 2019 Elanco. Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. Galliprant is a registered trademark of Aratana Therapeutics, Inc.

PM-US-19-1628